Printer Friendly
The Free Library
14,507,882 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biopharmaceutics, Inc. Announces Trading Symbol Change.


BELLPORT, N.Y.--(BUSINESS WIRE)--May 1, 1996--Biopharmaceutics, Inc. (BOPH BOPH Board of Parole Hearings (Canada; also seen as BPH) :OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
) announced today that its trading symbol Trading symbol

See: Ticker symbol
 has been changed to BOPH from BIOP BIOP Baghdad International Airport
BIOP Broadcast Inter-ORB Protocol
BIOP Burst Idle Optical Protocol
BIOP Basis of Issue Plan
BIOP Bureau d'Information et d'Orientation Professionnelles (French) 
 effective immediately. Its former symbol, BIOP, was assigned by NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
 to Biopsys Medical, Inc.

Edward Fine, Biopharmaceutics' President, also stated, "Our first full month of marketing our new Feminine Hygiene Products has now been completed. Sales from the new line of products are meeting expectations and, when combined with our pharmaceutical sales, are expected to generate a profit for the month of April. During the month of April, we received both chain store and wholesaler orders for the Feminine Hygiene products and our sales force converted most of the chains previously purchasing the products from the former marketer over to us. The Feminine Hygiene Products are carried by virtually all major drug wholesalers, food and drug chains. We were very pleased with our first month's accomplishments."

CONTACT: Stuart Fine, 516/286-5800
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 1, 1996
Words:155
Previous Article:Equity Corporation International completes offering of 2,990,000 shares of common stock.
Next Article:Galaxy Foods gains additional distribution in the Southwest.
Topics:



Related Articles
DR. BRUCE MIGDALOF JOINS BRADLEY PHARMACEUTICALS AS VICE PRESIDENT, CLINICAL RESEARCH AND DEVELOPMENT.
Biopharmaceutics signs asset purchase agreement.
Biopharmaceutics completes acquisition of Feminine Hygiene Product Lines.
Biopharmaceutics Signs Letter of Intent to Develop Cancer Drug.
Biopharmaceutics announces new board appointment.
Biopharmaceutics Inc. appoints new director.
First United Equities Corp. will not close offering of Apollo.
Biopharmaceutics, Inc. Announces Signing of Contract.
Biopharmaceutics, Inc. Completes Short-Term Debt Restructuring.
New journals from American Scientific Publishers.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles